Target (CBDY) Interest Expenses (2014 - 2026)
Target (CBDY) reported Interest Expenses of $288249.0 for Q1 2026, up 14.95% year-over-year from $250766.0 in Q1 2025, and up 9.7% quarter-over-quarter from $262767.0 in Q4 2025.
Target (CBDY) Interest Expenses (2014 - 2026) Analysis & Trends
Target (CBDY) has 13 years of Interest Expenses data on file, last reported at $288249.0 in Q1 2026.
- Interest Expenses for Q1 2026 came in at $288249.0, up 14.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 2.53% YoY), and the FY2025 annual result was $1.0 million, down 9.48% from the prior year.
- Interest Expenses climbed to $288249.0 in Q1 2026 per CBDY's latest filing, from $262767.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $747106.4 in Q2 2022 and troughed at $8.0 in Q1 2022.
- A 5-year average of $274989.1 and a median of $268186.0 in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses plunged 100.0% in 2022, then jumped 3493160.0% in 2024.
- A 5-year view of Interest Expenses shows it stood at $115174.7 in 2022, then jumped by 204.41% to $350601.0 in 2023, then dropped by 24.99% to $263002.0 in 2024, then retreated by 0.09% to $262767.0 in 2025, then rose by 9.7% to $288249.0 in 2026.
- Business Quant data shows CBDY's Interest Expenses at $288249.0 in Q1 2026, $262767.0 in Q4 2025, and $266716.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 20.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 4.86 Mn |
| 10 | Target | - | - | 191,787.00 | 288,249.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 288,249.00 |
| Mar 31, 2026 | 288,249.00 |
| Dec 31, 2025 | 262,767.00 |
| Dec 31, 2025 | 262,767.00 |
| Sep 30, 2025 | 266,716.00 |
| Sep 30, 2025 | 266,716.00 |
| Jun 30, 2025 | 263,970.00 |
| Jun 30, 2025 | 263,970.00 |
| Mar 31, 2025 | 250,766.00 |
| Mar 31, 2025 | 250,766.00 |
| Dec 31, 2024 | 263,002.00 |
| Dec 31, 2024 | 263,002.00 |
| Sep 30, 2024 | 268,186.00 |
| Sep 30, 2024 | 268,186.00 |
| Jun 30, 2024 | 273,060.00 |
| Jun 30, 2024 | 273,060.00 |
| Mar 31, 2024 | 349,326.00 |
| Mar 31, 2024 | 349,326.00 |
| Dec 31, 2023 | 350,601.00 |
| Dec 31, 2023 | 350,601.00 |